-
Product Insights
Bacteriology Rapid Tests and POC Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Bacteriology Rapid Tests & POC comprises rapid test kits intended for rapid diagnosis, with immediate results, through immuno assays for Chlamydia, H. pylori, Streptococci, and Syphilis. The Bacteriology Rapid Tests & POC pipeline market research report provides comprehensive information about the Bacteriology Rapid Tests & POC pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Sector Analysis
Glioblastoma Multiforme: Global Drug Forecast and Market Analysis to 2030
Glioblastoma multiforme (GBM) is now defined by the WHO 2021 as a diffuse astrocytic glioma with no mutations in IDH genes or histone H3 genes. It is the most common primary brain tumor in humans. Like other astrocytomas, GBM originates from astrocytes, a type of glial cells that are non-neuronal and function to provide structural and biochemical support to the brain's neuronal network. GBM continues to be a disease with some of the highest unmet needs in oncology, with patients...
-
Product Insights
Troponin Rapid Tests and Point of Care (POC) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
Troponin rapid tests & point of care (POC) are point-of-care diagnostic tests that enable to the measurement of troponin levels specific to cardiovascular diseases in a patient’s sample. The troponin rapid tests & point of care pipeline product market report provides key information and data related to extensive coverage of the troponin rapid tests & point of care under development. The report also provides details of major pipeline products which include product description, licensing and collaboration details, and other developmental...
-
Product Insights
Reproductive Hormones and Proteins Tests Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
Reproductive hormones and proteins assist in the control and regulation of physiological processes including metabolism, reproduction, and growth and development. They are secreted either from endocrine glands or from organs with secondary endocrine function (such as the pancreas, liver, kidneys, and gonads) and affect the health and behavior of both males and females. GlobalData's Medical Devices sector report, “Reproductive Hormones and Proteins Tests - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Reproductive Hormones and Proteins Tests...
-
Product Insights
Retrovirus Rapid Tests and POC – Medical Devices Pipeline Assessment, 2020
Retrovirus Rapid Tests are the diagnostic tests used for rapid diagnosis, with immediate results to detect the antigen/antibody of HIV1, HIV 2 (human immunodeficiency virus) and HTLV I, HTLV II (human T-cell lymphotropic virus) viruses. GlobalData's Medical Devices sector report, “Retrovirus Rapid Tests & POC-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Retrovirus Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are...
-
Product Insights
Parasitology and Mycology Rapid Tests and POC – Medical Devices Pipeline Assessment, 2020
Parasitology & Mycology Rapid Tests & POC comprises of rapid test kits intended for rapid diagnosis, with immediate results, through immuno assays for the detection of pathogenic protozoans and fungi. GlobalData's Medical Devices sector report, “Parasitology & Mycology Rapid Tests & POC-Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Parasitology & Mycology Rapid Tests & POC pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in...
-
Sector Analysis
Glioblastoma Multiforme (GBM): Opportunity Analysis and Forecasts to 2027
Glioblastoma multiforme (GBM), otherwise known as Grade IV astrocytoma, is the most aggressive form of brain cancer and characterized as a disease with one of the highest unmet needs in oncology, with patients having a median overall survival (OS) between one and two years. The lack of approved therapies is mainly due to the inability of drugs to penetrate the blood-brain barrier (BBB). The only targeted agent approved for recurrent GBM patients is Roche’s Avastin (bevacizumab), approved in the US...